SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, DC 20549
FORM 8-K
____________________________
CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF
THE SECURITIES EXCHANGE ACT OF 1934
Date of Report (Date of Earliest Event Reported): November 19, 2008
____________________________
Quest Diagnostics Incorporated
(Exact Name of Registrant as Specified in Its Charter)
___________________________
Delaware
(State or other jurisdiction of Incorporation)
|
|
|
|
|
001-12215 |
|
16-1387862 |
|
(Commission File Number)
|
|
(I.R.S. Employer Identification No.) |
|
|
|
|
|
Three Giralda Farms Madison, NJ 07940 |
|
07940 |
|
(Address of principal executive offices) |
|
(Zip Code) |
|
|
|
|
|
(973) 520-2700 | ||
|
(Registrant’s telephone number, including area code) | ||
|
|
|
|
___________________________
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction a.2. below):
o |
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
o |
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
o |
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
o |
Pre-commencement communications pursuant to Rule 13e-4(c) under the exchange Act (17 CFR 240.13e-4(c)) |
|
|
|
|
Item 8.01. Other Events
Effective November 19, 2008, the Board of Directors of Quest Diagnostics Incorporated (the “Company”) expanded the Company’s common stock share repurchase authorization by an additional $150 million.
Signature
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, hereunto duly authorized.
| November 24, 2008 | |||
| QUEST DIAGNOSTICS INCORPORATED | |||
| By: | /s/ William J. O’Shaughnessy, Jr. | ||
| William J. O’Shaughnessy, Jr. Assistant General Counsel and Secretary |
|||